TPG-Axon Capital
View More Recent Stories
-
TPG-Axon Sends Letter to Sandridge (SD) Holders to Vote for Green Card
-
TPG-Axon Issues Rebuttal to SandRidge (SD) Statement
-
TPG-Axon Commences Consent Solicitation for SandRidge (SD) Shares
-
Spirit Realty (SRC), CCPT II Enter Merger Agreement
-
SandRidge Energy (SD) Fights Back Against Allegations by TPG-Axon
-
Activist Target SandRidge Energy (SD) Jumps Into the Close
-
Stocks Crossing 50-Day SMA 12/28: (MHR) (GGB) (YONG) Above; (VVUS) (SD) (AUQ) Below
-
TPG-Axon Raises Stake in SandRidge Energy (SD) to 6.73%
-
TPG-Axon Files Consent Solicitation for SandRidge (SD); Wants to Replace Entire Board
-
TPG-Axon Sends Letter to SandRidge (SD); Files Lawsuit, Will Issue Consent Solicitation
-
SandRidge Energy (SD) Received Constent to Amend Bylaws, Remove Directors
-
TPG-Axon Launches Dedicated Website to Garner Support Against SandRidge (SD) Management
-
TPG-Axon Reiterates Stance on SandRidge (SD) Selling Itself, Comments on Q3 Numbers
-
Mount Kellett Sends Letter to SandRidge (SD) Board; Looks for Ouster of CEO Ward
-
Singh's TPG-Axon Enters Dollar General (DG), GNC (GNC), Green Mountain (GMCR), (more...)
-
UPDATE: TPG-Axon Raises Stake in Sandridge Energy, Inc. (SD) to 6.2%; Wants CEO Replaced, Explore a Sale
-
SandRidge (SD) Issues Reponse to TPG-Axon Letter; to Provide More Insight on Q3 Call
-
SandRidge (SD) Shows Heavy Volume as Holder Seeks Changes
-
TPG-Axon Shows New Stake in Express Scripts (ESRX), Buys More TD Ameritrade (AMTD); Liquidates Sprint (S) and Triquent (TQNT)
-
Singh's TPG-Axon Makes a Big New Bet On a Sirius XM (SIRI)
-
TPG-Axon Capital Boost Stake In Zhongpin (HOGS) Above 5%
-
In Large Hedge Fund Deal, TPG-Axon Acquires Montrica Investment
-
TPG-Axon Bumps National City (NCC) Stake, Then Drops Below 5% Threshold
-
TPG-Axon Capital Discloses 5.2% Stake in Arch Coal (ACI)
-
Unusual 11 Mid-Day Movers 4/16: POZN, SORC, EXM, GRO Higher; TLB, HCSG, GLG, CDL Lower
-
Pre-Open Movers 4/16: POZEN (POZN) Surges On FDA Approval; Movado (MOV) Higher on Upgrade
-
After-Hours Movers 4/15: Intel (INTC) Up on Results, CV Therapeutics (CVTX) Higher After Selling Drug Rights
-
CV Therapeutics (CVTX) to Receive $185 Million From TPG-Axon Capital for Half of Royalty for Lexiscan Injection
-
CV Therapeutics (CVTX) Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
-
TPG-Axon Capital Discloses 5.5% Stake in Goodyear Tire (GT)

